Skip to content

Medpace Holdings, Inc. MEDP Business Segments — SG&A

Similar metrics at other companies

Globus Medical logo
GMEDReportable Segment — Other Selling, General and Administrative Expense
$58.43M+28.1%
MACOM Technology Solutions logo
MTSIReportable Segment — Selling, general and administrative (1)
$29.52M+16.1%
Madrigal Pharmaceuticals, Inc. logo
MDGLReportable Segment — SG&A
$239.98M+69.9%
Exelixis logo
EXELReportable Segment — Selling, general, and administrative
$122.87M+1.7%
Rollins logo
ROLReportable Segment — Sales, general and administrative
$282.92M+12.9%
Biogen logo
BIIBReportable Segment — SG&A
$608.4M+1.2%

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s business segments — sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s business segments — SG&A?
Medpace Holdings, Inc. (MEDP) reported business segments — SG&A of $47.92M in Q1 2026.
How has Medpace Holdings, Inc.'s business segments — SG&A changed year-over-year?
Medpace Holdings, Inc.'s business segments — SG&A decreased by 17.2% year-over-year, from $57.9M to $47.92M.
What is the long-term trend for Medpace Holdings, Inc.'s business segments — SG&A?
Over 3 years (2022 to 2025), Medpace Holdings, Inc.'s business segments — SG&A has grown at a 14.6% compound annual growth rate (CAGR), from $131.4M to $197.56M.
What does business segments — SG&A mean?
The overhead and administrative costs required to run the business segment.
How do you interpret business segments — SG&A?
Rising costs may indicate scaling for future growth, while excessive growth relative to revenue could signal inefficient administrative overhead.
How does business segments — SG&A compare across companies?
Standard SG&A metric used across all industries to measure corporate overhead efficiency.